Zhou Chenyang, Li Zhangjie, Lu Kangyi, Liu Yijun, Xuan Lian, Mao Hongju, Wang Xiaolin
Department of Micro/Nano Electronics, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Institute of Medical Robotics, Shanghai Jiao Tong University, Shanghai 200240, China.
Fundam Res. 2024 Feb 22;5(3):1258-1272. doi: 10.1016/j.fmre.2023.12.019. eCollection 2025 May.
The limitations of conventional animal tests and two-dimensional cell culture hinder their advancement in fundamental research and clinical/translational applications. As an emerging alternative technology, organ-on-a-chip serves as a platform that faithfully simulates the key phenotypical, physiological, and functional features of human tissues/organs through the accurate regulation of the parameters such as physical and biochemical microenvironment, as well as cellular patterns. In this review, we mainly introduce the recent progress in the organ-on-a-chip field, including lung, gut, heart, liver, vasculature and multiorgan studies. Furthermore, we highlight the potential applications in drug screening and personalized medicine. Finally, we conclude the review by addressing the current challenges and future perspective in the technology and commercialization of organ-on-chips. We anticipate that the development of organ-on-a-chip technology will revolutionize the studies on biology and medicine by providing new understanding of mechanisms of diseases and insights into clinical therapeutics.
传统动物试验和二维细胞培养的局限性阻碍了它们在基础研究以及临床/转化应用方面的进展。作为一种新兴的替代技术,芯片器官作为一个平台,通过精确调控物理和生化微环境以及细胞模式等参数,忠实地模拟人体组织/器官的关键表型、生理和功能特征。在这篇综述中,我们主要介绍芯片器官领域的最新进展,包括肺、肠道、心脏、肝脏、血管系统和多器官研究。此外,我们强调其在药物筛选和个性化医疗方面的潜在应用。最后,我们通过阐述芯片器官技术及其商业化目前面临的挑战和未来前景来总结这篇综述。我们预计,芯片器官技术的发展将通过提供对疾病机制的新认识和临床治疗的见解,彻底改变生物学和医学研究。